Cart
sales@molnova.com
Oxmetidine
CAS No. 72830-39-8
Oxmetidine( —— )
Catalog No. M36209 CAS No. 72830-39-8
Oxmetidine (SKF 92994) is a novel H2 receptor antagonist that is cytotoxic. Oxmetidine inhibits transmembrane calcium flux in cardiac and vascular tissues and is used in the treatment of active duodenal ulcers.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 896 | In Stock |
|
| 10MG | 1216 | In Stock |
|
| 25MG | 1786 | In Stock |
|
| 50MG | 2390 | In Stock |
|
| 100MG | 3218 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 6464 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOxmetidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionOxmetidine (SKF 92994) is a novel H2 receptor antagonist that is cytotoxic. Oxmetidine inhibits transmembrane calcium flux in cardiac and vascular tissues and is used in the treatment of active duodenal ulcers.
-
DescriptionOxmetidine (SKF 92994) is a novel H2 receptor antagonist that is cytotoxic. Oxmetidine inhibits transmembrane calcium flux in cardiac and vascular tissues and is used in the treatment of active duodenal ulcers.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorHistamine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number72830-39-8
-
Formula Weight399.47
-
Molecular FormulaC19H21N5O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1NC(=NC=C1CC2=CC=C3OCOC3=C2)NCCSCC=4NC=NC4C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Loratadine
A tricyclic antihistamine that acts as a selective inverse agonist of peripheral histamine H1-receptors.
-
Pitolisant hydrochlo...
A potent and selective antagonist of H3 receptor with Ki/EC50 of 0.16/1.5 nM.
-
Xylocaine
Lidocaine, an amide local anesthetic, has anti-inflammatory properties in vitro and in vivo, possibly due to an attenuation of pro-inflammatory cytokines.
